Moreover, high SYK phosphorylation correlates with poor event-free and relapse-free survival in the subset of AML patients with complete clinical profiles within our cohort, both with and without stratification for H and H/M expression (Figures 2E, 2F, S2D, and S2E). Here, SYK is linked to acute myeloid leukemia.